Paper32555352
The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway.
Lv B and 3 others. Cancer Gene Ther, 2021. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway. Papers, record 32555352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32555352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Nasopharyngeal Carcinoma | Major topic |
| Nasopharyngeal Neoplasms | Major topic |
| Nuclear Proteins | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Transcription Factors | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Down-Regulation | |
| Female | |
| Genes, Tumor Suppressor | |
| Humans | |
| Male | |
| Middle Aged | |
| Signal Transduction |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30483794 | miR‑1271‑5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/30483794 | PubMed |
| 2 | 28577975 | Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma. | Cancer Lett | 2017 | https://conductscience.org/library/papers/28577975 | PubMed |
| 3 | 25531331 | MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells. | Oncogene | 2015 | https://conductscience.org/library/papers/25531331 | PubMed |
| 4 | 25683176 | A major role for microRNAs in glioblastoma cancer stem-like cells. | Arch Pharm Res | 2015 | https://conductscience.org/library/papers/25683176 | PubMed |
| 5 | 22733541 | The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22733541 | PubMed |
| 6 | 22253443 | Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22253443 | PubMed |
| 7 | 26426078 | ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells. | J Clin Invest | 2015 | https://conductscience.org/library/papers/26426078 | PubMed |
| 8 | 20965651 | MicroRNAs, cancer and cancer stem cells. | Cancer Lett | 2011 | https://conductscience.org/library/papers/20965651 | PubMed |
| 9 | 20053927 | microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. | Carcinogenesis | 2010 | https://conductscience.org/library/papers/20053927 | PubMed |
| 10 | 25158069 | Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy. | Stem Cell Res Ther | 2014 | https://conductscience.org/library/papers/25158069 | PubMed |
| 11 | 25670861 | MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1. | J Biol Chem | 2015 | https://conductscience.org/library/papers/25670861 | PubMed |
| 12 | 28583401 | miR-873 suppresses H9C2 cardiomyocyte proliferation by targeting GLI1. | Gene | 2017 | https://conductscience.org/library/papers/28583401 | PubMed |
| 13 | 30260270 | Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer. | Cancer Biol Ther | 2018 | https://conductscience.org/library/papers/30260270 | PubMed |
| 14 | 29344850 | HuR facilitates cancer stemness of lung cancer cells via regulating miR-873/CDK3 and miR-125a-3p/CDK3 axis. | Biotechnol Lett | 2018 | https://conductscience.org/library/papers/29344850 | PubMed |
| 15 | 29203970 | Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis. | Mediators Inflamm | 2017 | https://conductscience.org/library/papers/29203970 | PubMed |
| 16 | 26318045 | Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2. | Oncotarget | 2015 | https://conductscience.org/library/papers/26318045 | PubMed |
| 17 | 22877147 | Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells. | Expert Opin Ther Targets | 2012 | https://conductscience.org/library/papers/22877147 | PubMed |
| 18 | 21661123 | Zic2 synergistically enhances Hedgehog signalling through nuclear retention of Gli1 in cervical cancer cells. | J Pathol | 2011 | https://conductscience.org/library/papers/21661123 | PubMed |
| 19 | 19262572 | MicroRNAs--the micro steering wheel of tumour metastases. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19262572 | PubMed |
| 20 | 28810875 | Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. | J Transl Med | 2017 | https://conductscience.org/library/papers/28810875 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42158861 | Epigenetics: the master switch of nasopharyngeal carcinoma invasion and metastasis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42158861 | PubMed |
| 41750326 | Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation. | Biomolecules | 2026 | https://conductscience.org/library/papers/41750326 | PubMed |
| 41694394 | ZIC2 drives colorectal cancer progression by regulating QPRT-mediated cell migration. | Front Immunol | 2026 | https://conductscience.org/library/papers/41694394 | PubMed |
| 41266464 | ZIC5, a survival biomarker, facilitates tumor progression and stemness in colon cancer via the activation of the Wnt signaling pathway. | Sci Rep | 2025 | https://conductscience.org/library/papers/41266464 | PubMed |
| 38594503 | Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with both bulk and cancer stem cells in epithelial ovarian cancer. | Oncogene | 2024 | https://conductscience.org/library/papers/38594503 | PubMed |
| 38028735 | Circulating long non-coding RNA EWSAT1 acts as a liquid biopsy marker for esophageal squamous cell carcinoma: A pilot study. | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/38028735 | PubMed |
| 37496990 | FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37496990 | PubMed |
| 34805186 | Competitive Endogenous RNA Landscape in Epstein-Barr Virus Associated Nasopharyngeal Carcinoma. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34805186 | PubMed |
| 34676171 | MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis. | Front Oncol | 2021 | https://conductscience.org/library/papers/34676171 | PubMed |
| 34628845 | [Research progress of cancer stem cell biomarkers in head and neck squamous cell carcinoma]. | Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2021 | https://conductscience.org/library/papers/34628845 | PubMed |
| 34218325 | Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C. | J Cancer Res Clin Oncol | 2021 | https://conductscience.org/library/papers/34218325 | PubMed |
| 33760180 | Galectin‑3 facilitates the proliferation and migration of nasopharyngeal carcinoma cells via activation of the ERK1/2 and Akt signaling pathways, and is positively correlated with the inflammatory state of nasopharyngeal carcinoma. | Mol Med Rep | 2021 | https://conductscience.org/library/papers/33760180 | PubMed |
| 33335425 | Long Noncoding RNA LINC01426 Sequesters microRNA-519d-5p to Promote Non-Small Cell Lung Cancer Progression by Increasing ETS1 Expression. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33335425 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| MIR873 | 100126316 | PubTator's text mining | https://conductscience.org/library/genes/100126316 | NCBI Gene |
| PROM1 | 8842 | PubTator's text mining | https://conductscience.org/library/genes/8842 | NCBI Gene |
| ZIC2 | 7546 | PubTator's text mining | https://conductscience.org/library/genes/7546 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32555352
GET https://conductscience.org/api/papers/v1/32555352/references?page=2